Top Markets
#1 EXOD EXOD +56.80%
#2 Cysic Cysic +13.33%
#3 Bedrock Bedrock +8.66%
#4 Fabric Protocol Fabric Protocol +7.70%
#5 Cap Cap +5.10%
#6 Perle Perle +4.46%
#7 Dual Dual +3.60%
#8 The Black Bull The Black Bull +3.49%
#9 Figure Heloc Figure Heloc +3.49%
#10 Collector Crypt Collector Crypt +3.28%
Coin of the day
EXOD EXOD
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Pascal Biosciences Inc. Pascal Biosciences Inc.

Pascal Biosciences Inc.

PSCBF
Peringkat dalam Saham #37975
Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to... Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for oncology and bolstering immune system function. The company's robust pipeline includes several key candidates: PAS-403, a potent mitosis inhibitor designed to impede cancerous cell division, specifically targeting glioblastoma and secondary brain tumors; and PAS-393, an immunomodulatory cannabinoid developed to enhance the immune system's recognition of tumor cells when utilized alongside checkpoint inhibitor therapy. Furthermore, Pascal is progressing a specialized antibody therapy aimed at B-cells, intended for conditions like acute lymphoblastic leukemia and various B-cell lymphomas. The company is also investigating cannabinoid-derived products as potential treatments for COVID-19. To support its research, Pascal Biosciences maintains an exclusive licensing agreement with the University of Washington for a cannabinoid-based therapeutic against glioblastoma multiforme and brain metastases. It also benefits from a collaborative research partnership with SoRSE Technology Corporation, focused on advancing PAS-393 toward clinical trials. Founded in 2011, the company operates from its headquarters in Seattle, Washington.
Harga Saham
$0.1
Terakhir disinkronkan: 2024-06-18
Kapitalisasi Pasar
$1.31M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Pascal Biosciences Inc. (PSCBF)

Kategori

Healthcare
Margin Operasi untuk Pascal Biosciences Inc. (PSCBF)
Margin Operasi per August 2026 TTM: -133.68%
Menurut laporan keuangan dan harga saham terbaru dari Pascal Biosciences Inc., margin operasi saat ini (TTM) adalah -133.68%. Pada akhir 2022, margin operasi perusahaan adalah 0.00%.
Riwayat margin operasi untuk Pascal Biosciences Inc. dari 2019 hingga 2026
Margin Operasi pada akhir setiap tahun
Tahun Margin Operasi Mengubah
2026 (TTM) -133.68% 0.00%
2023 -133.68% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
Margin Operasi untuk perusahaan sejenis atau pesaing
Perusahaan Margin Operasi Perbedaan Margin Operasi Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.97% -100.29%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -100.22%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00% -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
31.23% -100.23%
BE
Apa itu Margin Operasi perusahaan?
Margin Operasi adalah indikator utama untuk menilai profitabilitas suatu perusahaan. Margin Operasi yang lebih tinggi umumnya lebih baik karena menunjukkan bahwa perusahaan mampu menjual produk atau layanan mereka dengan harga yang jauh lebih tinggi daripada biaya produksinya. Margin Operasi dihitung dengan membagi laba perusahaan dengan pendapatannya.